SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma

Figure 1

SLC2A5 is highly expressed in LUAD. (a) The expression level of SLC2A5 in different types of tumor tissues and normal tissues in the Oncomine database. ( value is 0.05, data type is mRNA, and gene ranking of all.) (b) The expression level of SLC2A5 in different types of tumor tissues and normal tissues in the TIMER database (, , and ). (c–f) The expression of SLC2A5 in LUAD is higher than that in normal tissues in different databases (SLC2A5 expression in Su’s dataset, Hou’s dataset, Stearman’s dataset, and Okayama’s dataset) in Oncomine. (g) High expression of SLC2A5 mRNA in LUAD tissues () compared with the normal tissues () in the GEPIA database. (h) High protein expression of SLC2A5 in LUAD tissues () compared with the normal tissues () in the UALCAN database. (i) Immunohistochemistry (IHC) of SLC2A5 expression in LUAD tissues and corresponding normal tissues based on HPA.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)